StockData

Danaher vs Keysight Technologies

DHR and KEYS side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DHR and KEYS compare

Danaher is the larger company, worth 3.2 times as much as Keysight Technologies ($167B against $52.3B).

On earnings, Keysight Technologies is cheaper: it trades at 42.1× trailing earnings, against 42.1× for Danaher.

Keysight Technologies grew revenue faster over the last twelve months (25.5% versus 4.6% for Danaher).

Keysight Technologies keeps more of each dollar of sales as profit, with a net margin of 19.1% compared with 15.9% at Danaher.

Danaher pays a dividend yielding 0.64%; Keysight Technologies does not pay one.

Keysight Technologies scores higher on the StockData Score (14 against 12 for Danaher), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDHRKEYS
Size and price
Market cap$167B$52.3B
Share price$236.98$307.20
Change, 1 year9.3%80.2%
Change, 5 years−18.9%67.2%
Beta (5Y)0.941.38
Employees60K17K
StockData Score
Total score1214 (better)
Valuation score11
Growth score12 (better)
Performance score25 (better)
Health score56 (better)
Dividend score3 (better)0
Valuation
P/E42.1×42.1× (better)
P/S6.6× (better)7.9×
P/B3.2× (better)8.0×
EV/EBITDA36.8× (better)39.2×
P/FCF30.5× (better)35.6×
FCF yield3.3% (better)2.8%
Fair value$186.55$245.85
Margin of safety−27.0%−25.0% (better)
Growth
Revenue growth (TTM)4.6%25.5% (better)
Revenue growth, 5Y average2.0%5.0% (better)
Net income growth (TTM)17.3%132% (better)
EPS growth (TTM)19.8%132% (better)
EPS growth, 5Y average0.65%8.2% (better)
Profitability
Gross margin58.5%64.7% (better)
Operating margin20.4% (better)20.3%
Net margin15.9%19.1% (better)
FCF margin21.8%22.3% (better)
Return on equity7.6%20.6% (better)
Return on invested capital6.1%21.3% (better)
Financial health
Debt / equity0.510.38 (better)
Net debt / EBITDA4.33 (better)−0.07
Interest coverage17.6× (better)12.3×
Current ratio1.652.02 (better)
Altman Z-score3.778.01 (better)
Piotroski F-score66
Dividends and buybacks
Dividend yield0.64%–
Payout ratio24.1%–
Buyback yield1.7% (better)1.2%
Shareholder yield2.4% (better)1.2%
Ownership
Held by institutions82.2%90.6%
Held by insiders8.9%0.72%
Insider net buying, 12 months−$128M−$32.5M (better)
Superinvestors holding10 (better)2
Short interest, % of float1.4%1.4%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.